An Introduction to Amyloid-Related Imaging Abnormalities (ARIA) and Its Management

This CME course will explain the phenomenon of ARIA, along with its epidemiology, presentation, prognosis and management. Attendees will also review case studies.

Biofluid Based Biomarkers in Neuropsychiatric Syndromes - The Early Career Researcher Webinar

The purpose of this webinar is to enhance knowledge on the potential use of biofluid biomarkers to assess neuropsychiatric diagnoses and drug response in dementia with Lewy bodies as well as in preclinical and prodromal Alzheimer's disease.

Biofluid Based Biomarkers in Neuropsychiatric Syndromes - The Metabolic Derangements Webinar

The purpose of this webinar is to enhance knowledge on the potential use of biofluid based biomarkers specifically related to metabolic derangements to assess neuropsychiatric diagnoses and drug response.

Cognitive Screening and Testing in a Biomarker Era

Discussion about blood-based biomarker tests and new therapies for Alzheimer’s disease.

Creating a Path Forward: Diverse Representation in Clinical Trials for Alzheimer’s Disease

Clinical trial participation is low amongst diverse populations. The purpose of this course is so we to increase awareness on the importance of representation and provide clinicians with the tools and resources to effectively communicate around clinical trials and recruit their patients.

Early-Onset Alzheimer’s Disease

This CME course highlights the similarities and differences between early- and late-onset Alzheimer’s disease, and how onset impacts clinical management.

Engaging Health Systems in ALZ-NET: Transforming Clinical Practice, Research, Treatment and Care

June 27, 2023
Clinicians and providers face many challenges in managing patients with dementia. The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) is a resource to collect real-world data to accelerate research, transform clinical care practice and improve brain health outcomes.

Epidemiology of Dementia and Cognitive Decline in Diverse Populations

This CME course covers the racial disparities found in Alzheimer’s dementia using longitudinal and neuropathologic data, and further shows how select risk factors for diverse populations relate to cognitive aging.

Identifying and Assessing for Dementia

The purpose of this webinar is to enhance the knowledge of primary care clinicians around dementia warning signs and performing a comprehensive assessment in their clinics.

Moving Toward Sustainable Representation in Clinical Trials in ADRD

This webinar will address short- and long-term solutions to racial and ethnic disparities in Alzheimer’s Disease and Related Dementias (ADRD) clinical trials.